Who owns Travere Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TVTX from SEC Form 13F filings across 319 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 319 institutions disclosed 105.2M shares of Travere Therapeutics, Inc. worth $5.97B — about 112.5% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
319
13F holders
$5.97B
value, 2026 filers
112.5%
of shares outstanding (105.2M sh)
91
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TVTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 11.3M | $643.3M | 0.3% | 12.1% | new |
| 2 | BlackRock, Inc. | 8.0M | $455.7M | 0.0% | 8.6% | +2.9% |
| 3 | FMR LLC | 7.1M | $403.2M | 0.0% | 7.6% | -35.3% |
| 4 | BANK OF AMERICA CORP /DE/ | 4.6M | $259.5M | 0.0% | 4.9% | +239.6% |
| 5 | STATE STREET CORP | 4.3M | $241.8M | 0.0% | 4.6% | -14.2% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | $233.4M | 0.0% | 4.4% | +1.6% |
| 7 | PERCEPTIVE ADVISORS LLC | 3.8M | $213.2M | 3.2% | 4% | -9.4% |
| 8 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.8M | $159.8M | 0.2% | 3% | -14.0% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.6M | $146.0M | 0.2% | 2.7% | +163.0% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $134.8M | 0.0% | 2.5% | +0.1% |
| 11 | Rock Springs Capital Management LP | 2.2M | $123.8M | 6.0% | 2.3% | +47.4% |
| 12 | Kynam Capital Management, LP | 2.0M | $113.6M | 6.3% | 2.1% | +27.5% |
| 13 | Stephens Investment Management Group LLC | 1.9M | $106.5M | 1.1% | 2% | +4.3% |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 1.8M | $104.1M | 0.1% | 2% | -6.8% |
| 15 | EMERALD ADVISERS, LLC | 1.6M | $90.9M | 2.1% | 1.7% | +2.8% |
| 16 | ARMISTICE CAPITAL, LLC | 1.6M | $89.3M | 1.1% | 1.7% | -67.9% |
| 17 | TWO SIGMA INVESTMENTS, LP | 1.6M | $88.9M | 0.1% | 1.7% | +3.8% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5M | $87.6M | 0.0% | 1.6% | -9.8% |
| 19 | GOLDMAN SACHS GROUP INC | 1.5M | $87.2M | 0.0% | 1.6% | -10.7% |
| 20 | WELLINGTON MANAGEMENT GROUP LLP | 1.5M | $87.1M | 0.0% | 1.6% | +50.0% |
| 21 | Qube Research & Technologies Ltd | 1.4M | $82.0M | 0.1% | 1.5% | +115.7% |
| 22 | D. E. Shaw & Co., Inc. | 1.4M | $81.8M | 0.0% | 1.5% | +72.2% |
| 23 | Driehaus Capital Management LLC | 1.4M | $81.8M | 0.5% | 1.5% | +12.2% |
| 24 | MARSHALL WACE, LLP | 1.3M | $75.7M | 0.1% | 1.4% | +646.7% |
| 25 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.3M | $74.9M | 0.0% | 1.4% | +225.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.